Aqueous Humor as a Liquid Biopsy for Retinoblastoma: Clear Corneal Paracentesis and Genomic Analysis.
Aqueous Humor as a Liquid Biopsy for Retinoblastoma: Clear Corneal Paracentesis and Genomic Analysis.
复制标题
DOI：
10.3791/62939
复制
发表时间：
2021-09-07
影响因子：
1.2
通讯作者：
Berry, Jesse L.
中科院分区：
文献类型：
--
作者：
Kim, Mary E.;Xu, Liya;Prabakar, Rishvanth K.;Shen, Lishuang;Peng, Chen-Ching;Kuhn, Peter;Gai, Xiaowu;Hicks, James;Berry, Jesse L.
鉴于在视网膜母细胞瘤患者中禁止直接肿瘤活检，液体活检平台在视网膜母细胞瘤的应用具有重要的潜在临床应用价值。房水（AH）形成于与肿瘤分开的隔室，但被封闭在同一眼腔内。因此，它是眼睛特异性肿瘤基因组信息的丰富来源，可用于该疾病的液体活检或替代肿瘤活检。本文详细介绍了一种通过透明角膜穿刺从视网膜母细胞瘤眼睛中安全提取AH的方法。此外，还介绍了基因组分析的步骤，包括游离DNA的分离和纯化、下一代测序、体细胞拷贝数改变（SCNA）分析、RB1单核苷酸变异（SNV）突变鉴定和肿瘤分数估计。已经评估了AH液体活检平台的分析前、分析后和早期临床有效性；然而，它并非没有局限性。这在很大程度上是化验某些步骤所需的游离DNA数量的结果。与目前正在研究的视网膜母细胞瘤的其他基于血液的液体活检平台相比，基于ah的平台受到可以从眼睛中提取的生物流体体积（以及DNA数量）的限制；好处是AH是眼睛特异性的。这里讨论的平台的独特之处在于，它通过两种机制（SCNAs和RB1 snv）检测AH中的循环肿瘤DNA，从而在识别肿瘤基因组信息方面具有更高的灵敏度。AH液体活检具有直接临床应用于视网膜母细胞瘤患者精确肿瘤学的潜力，对于双侧疾病患者尤其重要，因为AH对每只眼睛的肿瘤都是特异性的。目前正在研究将该平台应用于其他眼部肿瘤患者。
There is significant potential clinical utility for the application of a liquid biopsy platform for retinoblastoma, given that direct tumor biopsy is prohibited in these patients. The aqueous humor (AH) forms in a separate compartment from the tumor but is enclosed within the same ocular space. Thus, it is an enriched source of eye-specific tumoral genomic information that can be used as a liquid biopsy or surrogate to tumor biopsy for this disease. This manuscript details a methodology for safely extracting the AH from retinoblastoma eyes via clear corneal paracentesis. Additionally, the steps for genomic analysis, including cell-free DNA isolation and purification, next-generation sequencing, somatic copy number alteration (SCNA) analysis, RB1 single nucleotide variant (SNV) mutation identification, and tumor fraction estimation are presented. The pre-analytical, analytical, and early clinical validity of the AH liquid biopsy platform have been evaluated; however, it is not without limitations. These are largely a consequence of the quantity of cell-free DNA that is required for certain steps of the assay. Compared to other blood-based liquid biopsy platforms currently under investigation for retinoblastoma, an AH-based platform is limited by the volume of biofluid (and thus the quantity of DNA) that can be extracted from the eye; the benefit is that AH is eye-specific. The platform discussed here is unique in that it detects circulating tumor DNA in the AH via two mechanisms (SCNAs and RB1 SNVs), yielding a higher sensitivity for identifying tumoral genomic information. The AH liquid biopsy has the potential for direct clinical application to precision oncology for retinoblastoma patients, with particular importance for patients with bilateral disease as the AH is specific to the tumors in each eye. There is ongoing research with applications of this platform to patients with other ocular tumors as well.
登录
查看更多内容
影响因子：
48
作者：
Huber W;Carey VJ;Gentleman R;Anders S;Carlson M;Carvalho BS;Bravo HC;Davis S;Gatto L;Girke T;Gottardo R;Hahne F;Hansen KD;Irizarry RA;Lawrence M;Love MI;MacDonald J;Obenchain V;Oleś AK;Pagès H;Reyes A;Shannon P;Smyth GK;Tenenbaum D;Waldron L;Morgan M
通讯作者：
Morgan M
影响因子：
5.2
作者：
Davies HR;Broad KD;Onadim Z;Price EA;Zou X;Sheriff I;Karaa EK;Scheimberg I;Reddy MA;Sagoo MS;Ohnuma SI;Nik-Zainal S
通讯作者：
Nik-Zainal S
影响因子：
2.7
作者：
Didion JP;Martin M;Collins FS
通讯作者：
Collins FS
影响因子：
45.3
作者：
Chévez-Barrios, P;Chintagumpala, M;Hurwitz, RL
通讯作者：
Hurwitz, RL
DOI：
10.1016/j.neo.2018.05.007
发表时间：
2018-08
期刊：
Neoplasia (New York, N.Y.)
影响因子：
--
作者：
Francis JH;Roosipu N;Levin AM;Brodie SE;Dunkel IJ;Gobin YP;Abramson DH
通讯作者：
Abramson DH